JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Factors determining stone-free rate in shock wave lithotripsy using standard focus of Storz Modulith SLX-F2 lithotripter.

Urology 2011 October
OBJECTIVES: To calculate the efficiency quotient (EQ) of the latest mobile Storz Modulith SLX-F2 lithotripter and to identify the factors determining the stone-free rate.

METHODS: A retrospective review of a prospectively collected database of the first consecutive 533 patients undergoing shock wave lithotripsy (SWL) from June 2009 to February 2010 was performed. A total of 16 patients with radiolucent stones and 43 patients with incomplete follow-up were excluded. The patients were followed up with plain radiography to assess the stone-free status. Univariate and multivariate analyses were performed to identify the factors determining the stone-free rates.

RESULTS: Follow-up was complete for 474 patients, with a mean age of 54.2 ± 14.5 years. The success rate after a single SWL session was 82.7% (renal 82.2% and ureteral 83.3%; P = .81). The retreatment rate was 14.7% (renal 15.2% and ureteral 14.2%; P = .79). The stone-free rate was 77% (renal 74.1% and ureteral 80.9%; P = .10). Of the 474 patients, 43 had pre-SWL ureteral stents, and 13 required post-SWL ureteral stenting; 35 patients required post-SWL curative procedures. The EQ was 0.66, and the modified EQ was 0.62. On multivariate analysis, the stone-free patients had a smaller stone size (9.5 vs 10.3 mm, P = .02), younger age (53.1 vs 58.0 years, P = .002), right-sided stones (83.6% vs 71.0% P = .001), and the absence of a ureteral stent (78.7% vs 64.3%; P = .001).

CONCLUSIONS: The mobile Storz Modulith SLX-F2 lithotripter has an acceptable EQ of 0.66. In the present study, smaller stones (<10 mm), younger age, right-sided stones, and the absence of ureteral stents were associated with significantly greater stone-free rates.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app